Equities research analysts forecast that The Advisory Board Company (NASDAQ:ABCO) will report $195.70 million in sales for the current quarter, Zacks reports. Ten analysts have issued estimates for The Advisory Board’s earnings, with the highest sales estimate coming in at $197.39 million and the lowest estimate coming in at $193.70 million. The Advisory Board reported sales of $198.38 million during the same quarter last year, which would suggest a negative year over year growth rate of 1.4%. The firm is scheduled to announce its next earnings report on Wednesday, July 26th.

According to Zacks, analysts expect that The Advisory Board will report full year sales of $195.70 million for the current fiscal year, with estimates ranging from $800.28 million to $814.70 million. For the next financial year, analysts expect that the business will post sales of $853.82 million per share, with estimates ranging from $818.54 million to $872.60 million. Zacks Investment Research’s sales calculations are an average based on a survey of analysts that follow The Advisory Board.

The Advisory Board (NASDAQ:ABCO) last released its quarterly earnings data on Thursday, May 4th. The business services provider reported $0.38 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.26 by $0.12. The business had revenue of $194.50 million during the quarter, compared to analysts’ expectations of $188.43 million. The Advisory Board had a return on equity of 14.48% and a net margin of 12.78%. The business’s quarterly revenue was down 3.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.44 EPS.

A number of equities analysts recently commented on the company. Robert W. Baird reiterated an “outperform” rating and issued a $65.00 price target (up from $57.00) on shares of The Advisory Board in a research note on Sunday, July 9th. Stifel Nicolaus reiterated a “hold” rating and issued a $53.00 price target (up from $48.00) on shares of The Advisory Board in a research note on Thursday, July 6th. Zacks Investment Research downgraded The Advisory Board from a “buy” rating to a “hold” rating in a research note on Wednesday, May 10th. Credit Suisse Group AG lifted their price target on The Advisory Board from $54.00 to $55.00 and gave the stock an “outperform” rating in a research note on Friday, May 5th. Finally, TheStreet downgraded The Advisory Board from a “b-” rating to a “c” rating in a research note on Friday, May 5th. One research analyst has rated the stock with a sell rating, six have given a hold rating and seven have issued a buy rating to the company. The Advisory Board has an average rating of “Hold” and an average target price of $49.31.

A number of institutional investors have recently modified their holdings of the company. BlackRock Inc. boosted its position in shares of The Advisory Board by 72,455.6% in the first quarter. BlackRock Inc. now owns 2,545,252 shares of the business services provider’s stock worth $119,119,000 after buying an additional 2,541,744 shares in the last quarter. Elliott Management Corp acquired a new position in shares of The Advisory Board during the first quarter worth about $95,047,000. Neuberger Berman Group LLC boosted its position in shares of The Advisory Board by 20,493.1% in the first quarter. Neuberger Berman Group LLC now owns 1,306,425 shares of the business services provider’s stock worth $61,141,000 after buying an additional 1,300,081 shares in the last quarter. Janus Capital Management LLC boosted its position in shares of The Advisory Board by 35.4% in the first quarter. Janus Capital Management LLC now owns 3,346,695 shares of the business services provider’s stock worth $156,622,000 after buying an additional 874,688 shares in the last quarter. Finally, First Eagle Investment Management LLC acquired a new position in shares of The Advisory Board during the first quarter worth about $24,907,000.

The Advisory Board (NASDAQ ABCO) traded up 0.53% during mid-day trading on Friday, hitting $57.20. The stock had a trading volume of 393,875 shares. The firm has a market cap of $2.32 billion, a PE ratio of 23.18 and a beta of 1.31. The company has a 50-day moving average of $53.07 and a 200-day moving average of $47.98. The Advisory Board has a 12-month low of $24.85 and a 12-month high of $59.50.

ILLEGAL ACTIVITY WARNING: This news story was reported by American Banking News and is the property of of American Banking News. If you are reading this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright law. The legal version of this news story can be read at https://www.americanbankingnews.com/2017/07/22/the-advisory-board-company-abco-expected-to-announce-quarterly-sales-of-195-70-million.html.

About The Advisory Board

The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company offers subscription-based membership programs, software and data-enabled services. All of its programs are rooted in best practices and extends across four areas, including Best practices research, Technology, Data-enabled services and Consulting services.

Get a free copy of the Zacks research report on The Advisory Board (ABCO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for The Advisory Board Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Advisory Board Company and related companies with MarketBeat.com's FREE daily email newsletter.